Your browser doesn't support javascript.
loading
Immune checkpoint inhibitors and radiosurgery for newly diagnosed melanoma brain metastases.
Robin, Tyler P; Breeze, Robert E; Smith, Derek E; Rusthoven, Chad G; Lewis, Karl D; Gonzalez, Rene; Brill, Amanda; Saiki, Robin; Stuhr, Kelly; Gaspar, Laurie E; Karam, Sana D; Raben, David; Kavanagh, Brian D; Nath, Sameer K; Liu, Arthur K.
Afiliación
  • Robin TP; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA. tyler.robin@ucdenver.edu.
  • Breeze RE; Department of Radiation Oncology, University of Colorado Cancer Center, 1665 Aurora Court, Suite 1032, MS F706, Aurora, CO, 80045, USA. tyler.robin@ucdenver.edu.
  • Smith DE; Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, USA.
  • Rusthoven CG; Department of Pediatrics, Cancer Center Biostatistics Core, University of Colorado and Children's Hospital Colorado, Aurora, CO, USA.
  • Lewis KD; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Gonzalez R; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
  • Brill A; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
  • Saiki R; Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, USA.
  • Stuhr K; Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, USA.
  • Gaspar LE; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Karam SD; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Raben D; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Kavanagh BD; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Nath SK; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Liu AK; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
J Neurooncol ; 140(1): 55-62, 2018 Oct.
Article en En | MEDLINE | ID: mdl-29909499
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Radiocirugia / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 / Melanoma / Anticuerpos Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: J Neurooncol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Radiocirugia / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 / Melanoma / Anticuerpos Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: J Neurooncol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos